HRT in the perimenopause. An alternative for patients that do not wish to menstruate. Preliminary study

Descripción del Articulo

OBJETIVE: The present work aims at evaluating a way to administrate a drug named tibolone, among a group of patients having it as the unique therapy of hormonal replacement, but who still have some type of uterine bleeding and who are not still having definite menopause. The indication for the use o...

Descripción completa

Detalles Bibliográficos
Autor: Siu, Alejandro
Formato: artículo
Fecha de Publicación:2015
Institución:Sociedad Peruana de Obstetricia y Ginecología
Repositorio:Revista Peruana de Ginecología y Obstetricia
Lenguaje:español
OAI Identifier:oai:ojs.pkp.sfu.ca:article/550
Enlace del recurso:http://51.222.106.123/index.php/RPGO/article/view/550
Nivel de acceso:acceso abierto
id REVSPOG_6e9909949c1090620cbf4373ba02a03b
oai_identifier_str oai:ojs.pkp.sfu.ca:article/550
network_acronym_str REVSPOG
network_name_str Revista Peruana de Ginecología y Obstetricia
repository_id_str .
spelling HRT in the perimenopause. An alternative for patients that do not wish to menstruate. Preliminary studyTerapia hormonal de reemplazo en la perimenopausia. Una alternativa para las pacientes que no deseen menstruar. Estudio preliminarSiu, AlejandroOBJETIVE: The present work aims at evaluating a way to administrate a drug named tibolone, among a group of patients having it as the unique therapy of hormonal replacement, but who still have some type of uterine bleeding and who are not still having definite menopause. The indication for the use of this drug is the presence of amenorrhea for at least one year. DESIGN: The idea is to administrate a combined hormonal treatment with pills derived from estrogens as well as progesterone in order to reduce to the minimal expression the endometrium, accompanied by an ultrasound assessment. RESULTS: It has been found that fifty percent of the studied patients responded satisfactorily to our therapeutic scheme. CONCLUSION: The fifty percent of the patients who have less than 7mm of endometrium, could use our therapy.OBJETIVO: El presente trabajo está dirigido a evaluar una manera de administrar un fármaco, la tibolona, para aquel grupo de pacientes que tendrían únicamente esa opción como terapia hormonal de reemplazo, pero que aún presentan algún tipo desangrado uterino y aún no están definitivamente en la menopausia. Debido a que la indicación para el uso de este fármaco, es la amenorrea mínima de un año. DISEÑO: La idea es administrar un tratamiento hormonal combinado con píldoras de derivados del estrógeno y la progesterona y abatir el endometrio, con la debida evaluación ecográfica, llevándolo a una atrofia o disminución mínima y luego prescribir la tibolona. RESULTADOS: Hemos encontrado que el cincuenta por ciento de las pacientes estudiadas respondieron satisfactoriamente a nuestro esquema terapéutico. CONCLUSIONES: La mitad de las pacientes usando nuestro esquema terapéutico, con endometrio abatido a menos de 7 mm, podrían beneficiarse con nuestra propuesta.Sociedad Peruana de Obstetricia y Ginecología2015-05-14info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttp://51.222.106.123/index.php/RPGO/article/view/550The Peruvian Journal of Gynecology and Obstetrics ; Vol. 48 No. 2 (2002); 124-126Revista Peruana de Ginecología y Obstetricia; Vol. 48 Núm. 2 (2002); 124-1262304-51322304-5124reponame:Revista Peruana de Ginecología y Obstetriciainstname:Sociedad Peruana de Obstetricia y Ginecologíainstacron:SPOGspahttp://51.222.106.123/index.php/RPGO/article/view/550/513info:eu-repo/semantics/openAccessoai:ojs.pkp.sfu.ca:article/5502015-07-30T22:38:24Z
dc.title.none.fl_str_mv HRT in the perimenopause. An alternative for patients that do not wish to menstruate. Preliminary study
Terapia hormonal de reemplazo en la perimenopausia. Una alternativa para las pacientes que no deseen menstruar. Estudio preliminar
title HRT in the perimenopause. An alternative for patients that do not wish to menstruate. Preliminary study
spellingShingle HRT in the perimenopause. An alternative for patients that do not wish to menstruate. Preliminary study
Siu, Alejandro
title_short HRT in the perimenopause. An alternative for patients that do not wish to menstruate. Preliminary study
title_full HRT in the perimenopause. An alternative for patients that do not wish to menstruate. Preliminary study
title_fullStr HRT in the perimenopause. An alternative for patients that do not wish to menstruate. Preliminary study
title_full_unstemmed HRT in the perimenopause. An alternative for patients that do not wish to menstruate. Preliminary study
title_sort HRT in the perimenopause. An alternative for patients that do not wish to menstruate. Preliminary study
dc.creator.none.fl_str_mv Siu, Alejandro
author Siu, Alejandro
author_facet Siu, Alejandro
author_role author
description OBJETIVE: The present work aims at evaluating a way to administrate a drug named tibolone, among a group of patients having it as the unique therapy of hormonal replacement, but who still have some type of uterine bleeding and who are not still having definite menopause. The indication for the use of this drug is the presence of amenorrhea for at least one year. DESIGN: The idea is to administrate a combined hormonal treatment with pills derived from estrogens as well as progesterone in order to reduce to the minimal expression the endometrium, accompanied by an ultrasound assessment. RESULTS: It has been found that fifty percent of the studied patients responded satisfactorily to our therapeutic scheme. CONCLUSION: The fifty percent of the patients who have less than 7mm of endometrium, could use our therapy.
publishDate 2015
dc.date.none.fl_str_mv 2015-05-14
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://51.222.106.123/index.php/RPGO/article/view/550
url http://51.222.106.123/index.php/RPGO/article/view/550
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv http://51.222.106.123/index.php/RPGO/article/view/550/513
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Sociedad Peruana de Obstetricia y Ginecología
publisher.none.fl_str_mv Sociedad Peruana de Obstetricia y Ginecología
dc.source.none.fl_str_mv The Peruvian Journal of Gynecology and Obstetrics ; Vol. 48 No. 2 (2002); 124-126
Revista Peruana de Ginecología y Obstetricia; Vol. 48 Núm. 2 (2002); 124-126
2304-5132
2304-5124
reponame:Revista Peruana de Ginecología y Obstetricia
instname:Sociedad Peruana de Obstetricia y Ginecología
instacron:SPOG
instname_str Sociedad Peruana de Obstetricia y Ginecología
instacron_str SPOG
institution SPOG
reponame_str Revista Peruana de Ginecología y Obstetricia
collection Revista Peruana de Ginecología y Obstetricia
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1845882455911825408
score 13.371646
HRT in the perimenopause. An alternative for patients that do not wish to menstruate. Preliminary study
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).

Ejemplares Similares